Bullish indicating open at $55-$60, IPO prices at $37
The W.K. Kellogg Foundation Trust, a ten percent owner in Kellanova (NYSE:K), reported selling 114,583 shares of common stock on July 14, 2025. The shares were sold at a price of $79.5442, for a total transaction value of $9,114,413. According to InvestingPro data, Kellanova, with a market capitalization of $27.64 billion, is currently trading slightly above its Fair Value, near its 52-week high of $83.22.
Following the transaction, the W.K. Kellogg Foundation Trust directly owns 45,784,952 shares of Kellanova. LaJune Montgomery Tabron, Steve Cahillane, Richard M. Tsoumas and The Northern Trust (NASDAQ:NTRS) Company are Trustees and the W.K. Kellogg Foundation is the sole beneficiary. The company maintains a solid 2.87% dividend yield and has maintained dividend payments for 55 consecutive years, demonstrating strong financial stability with a "GOOD" overall financial health score.
The sale was executed under a pre-arranged trading plan established on May 7, 2024, designed to comply with Rule 10b5-1(c) of the Securities and Exchange Act of 1934. Craig R. Carberry, Deputy General Counsel of The Northern Trust Company, signed the report as Corporate Trustee of the W.K. Kellogg Foundation Trust and for the W.K. Kellogg Foundation, under a power of attorney. For comprehensive insider trading analysis and additional insights, access the detailed Pro Research Report available on InvestingPro.
In other recent news, Kellanova’s pending acquisition by Mars has been a focal point of regulatory reviews. The U.S. Federal Trade Commission has concluded its antitrust review of the acquisition without imposing any conditions, leaving only the European Commission’s review outstanding. This development marks a significant milestone toward the merger, expected to close by the end of 2025, pending regulatory approval. The European Commission has initiated a Phase II investigation into the merger, expressing concerns over Mars’ market share in certain product categories within the EU. Analysts from Bernstein have maintained a Market Perform rating for Kellanova, noting potential risks if the European regulators reject the deal. Meanwhile, Citi has resumed coverage of Kellanova with a Neutral rating and an $83.50 price target, emphasizing the potential impact of the acquisition’s outcome on the company’s stock value. Kellanova reported $13 billion in net sales for 2023, underscoring its significance in the global snacking market. As the merger progresses, investors are closely monitoring these developments, given their potential implications for Kellanova’s future market performance.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.